S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 120 900 KRW -3.2%
Market Cap: 2.5T KRW

Wall Street
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 133 705 KRW with a low forecast of 101 000 KRW and a high forecast of 168 000 KRW.

Lowest
Price Target
101 000 KRW
16% Downside
Average
Price Target
133 705 KRW
11% Upside
Highest
Price Target
168 000 KRW
39% Upside
ST Pharm Co Ltd Competitors:
Price Targets
GENO
Genovis AB
70% Upside
300759
Pharmaron Beijing Co Ltd
28% Upside
MCAP
MedCap AB (publ)
15% Upside
INNOVACAP
Innova Captab Ltd
16% Upside
DIVISLAB
Divi's Laboratories Ltd
7% Upside
NANOFH
Nanoform Finland Oyj
146% Upside
ILMN
Illumina Inc
6% Downside
HVO
hVIVO PLC
162% Upside

Revenue
Forecast

Revenue Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 23%.

11%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 53%.

11%
Past Growth
53%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
ST Pharm Co Ltd

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 35%.

20%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ST Pharm Co Ltd's stock price target?
Price Target
133 705 KRW

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 133 705 KRW with a low forecast of 101 000 KRW and a high forecast of 168 000 KRW.

What is ST Pharm Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 23%.

What is ST Pharm Co Ltd's Operating Income forecast?
Projected CAGR
53%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 53%.

What is ST Pharm Co Ltd's Net Income forecast?
Projected CAGR
35%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 35%.

Back to Top